Community/Retail

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The dug will be commercially available to healthcare professionals and appropriate patients in the U.S. in the fourth quarter of 2019.

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses considerations when making the switch to IV robotics.

Cladosporium, Penicillium, Alternaria, and Aspergillus are the most common molds found in almost all environments.1 These are just a few of the hundreds of thousands of species of fungi.

Officials with the FDA have approved Alembic Pharmaceuticals’ Fenofibrate Tablets USP, 48 mg and 145 mg as an adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B).

Alembic Pharmaceuticals has received FDA approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%, therapeutically equivalent to Trusopt Ophthalmic Solution, 2% (Merck Sharp & Dohme Corp.).

Suzanne Soliman, PharmD, founder of the Pharmacist Moms Group, talks about her hopes for the future of the online community.

Genomind is expanding its mental health genetic testing services with the addition of Genomind Professional PGx Express, which provides a more focused report and set of services to enhance the preexisting mental health genetic test.

In an ideal world, how would you hypothesize that technology might be able to solve all of your problems?

What is causing the suspicious MRI results?

An FDA committee has recommended approval of Gilead’s Descovy to reduce the risk of sexually acquired HIV infection in those at high risk of acquiring the virus.

Daniel Griffis, PharmD, pharmacist at the Rainbow Drug Store, sat down with Pharmacy Times and discussed the various services that the pharmacy provides.

These new Guarded Luer Connectors are used to join two luer lock syringes or other luer lock devices.

As new pharmacists receive their exam results and enter the workforce, many are facing questions about their school experiences, career plans, further education plans, and the rising debt students face.

Pharmacy Times®, the leading multimedia pharmacy network, in conjunction with Parata Systems announces the 30 finalists for the 2019 Next-Generation Pharmacist® awards.

Lindsay Davis, PharmD, BCPS, ASH-CHC, TTS and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, both professors at t Midwestern University College of Pharmacy – Glendale, Glendale, AZ, discuss pharmacists as patient care providers, and managing patients taking anticoagulation medications.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), named public health expert and former commissioner of the Food and Drug Administration (FDA) Scott Gottlieb, M.D., as the keynote speaker for the 37th Annual Chemotherapy Foundation Symposium Innovative Cancer Therapy for Tomorrow.®

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses techniques to optimize the use of IV robotics in a hospital pharmacy setting.

High school students will explore pharmacy careers through activities such as extracting DNA from strawberries, and getting out of a pharmacy-themed escape room, during the upcoming Discover Pharmacy day camp, at Wilkes University.

Suzy Soliman, PharmD, discusses why pharmacist moms needed a space for themselves.

Vizient, Inc. has released its July 2019 Drug Price Forecast, which projects that health systems can expect a 4.57% increase for pharmaceutical purchases made in 2020.

Pharmacy and public health associations have released statements following the recent shootings in California, Texas, and Ohio, and some are discussing what actions they can take to prevent further gun-related injury and death.

Drug overdoses involving opioids have increased, and naloxone can be a life-saving drug to prevent deaths.

A study in the Bukoba municipality of Tanzania has suggested that scaling up HIV testing, improving linkages to HIV care, and strengthening retention of antiretroviral therapy interventions can help increase viral load suppression (VLS).

McKesson's Central Fill as a Service program can expand revenue opportunities for pharmacists—Joe Tammaro explains how.

Officials with the FDA issued a statement to clarify data accuracy issues with recently-approved gene therapy Zolgensma (onasemnogene abeparvovec-xioi, AveXis), a product intended to treat spinal muscular atrophy (SMA) in children under 2 years old.

An analysis of previous studies of children and young adults with ADHD has quantified the extent to which stimulant treatment reduces the development of mood disorders, problems in school, conduct disorders, substance use disorders, and other problems.

Tera Moore, PharmD, National Program Manager, VA Pharmacy Benefits Management office, discusses the shortage of psychiatrists and how integration of mental health professionals could help solve the issue.

The opioid epidemic has become widespread throughout the country, and it is considered a top public health priority.